United States Celiac Disease Market was valued at USD 1.8 Billion in 2022 and is projected to reach USD 3.1 Billion by 2030, growing at a CAGR of 7.4% from 2024 to 2030.
Start
The Us Celiac Disease Market Is Experiencing Rapid Growth, Driven By Increasing Awareness And A Rising Number Of Diagnoses. Celiac Disease, An Autoimmune Disorder Triggered By Gluten Ingestion, Affects Millions Of Americans, Creating A Substantial Demand For Gluten-Free Products, Medical Treatments, And Specialized Care. As The Population Becomes More Health-Conscious, The Market Has Been Expanding, With New Products And Treatments Emerging To Meet The Needs Of Patients.
The Market’S Growth Is Largely Attributed To The Increased Recognition Of Celiac Disease Among Healthcare Professionals And Patients. As More Individuals Are Diagnosed, The Demand For Gluten-Free Foods, Supplements, And Medications Is Rising. Gluten-Free Food Sales Alone Have Surged In Recent Years, With Brands Diversifying Their Offerings To Cater To The Growing Number Of People Seeking Safe And Delicious Options.
Alongside The Demand For Dietary Changes, Advancements In Medical Treatment Have Also Played A Pivotal Role. Pharmaceutical Companies Are Focusing On Developing Drugs That Can Help Manage The Symptoms Of Celiac Disease Or Even Offer A Potential Cure. Clinical Trials And Innovative Therapies Continue To Shape The Future Of This Market, Ensuring Better Treatment Options For Patients.
In Addition To Food And Pharmaceuticals, The Us Celiac Disease Market Encompasses A Range Of Services Such As Diagnostic Testing And Counseling. With A Higher Number Of Individuals Seeking Professional Guidance, The Market For These Services Is Growing Rapidly. The Healthcare System Is Also Adapting, Offering More Specialized Treatment Centers And Healthcare Professionals Skilled In Managing Celiac Disease.
Statistics Reveal That Around 1 In 100 People Worldwide Suffer From Celiac Disease, Making It A Prevalent Condition With Significant Market Potential. Experts Predict Continued Growth In The Celiac Disease Market Due To Better Awareness, Diagnostic Advancements, And Expanding Product Availability. As The Market Matures, It Aligns With The Wider Trends In Health And Wellness, Catering To Those With Specific Dietary Restrictions, Including Those Seeking Products Related To The "100 Gigabit Fiber Optic Transceiver Market" As An Example Of Rapid Innovation.
Ultimately, As Celiac Disease Awareness And Diagnosis Continue To Increase, The Market Will Likely See More Targeted Therapies And Even Greater Product Innovations Aimed At Improving The Quality Of Life For Those Affected By This Condition.
Get an In-Depth Research Analysis of the US Celiac Disease Market Size And Forecast [2025-2032]
Roche
Merck
Johnson & Johnson
BiolineRx
Pfizer
Innovate Biopharmaceuticals
ImmusanT
Novartis
Bristol-Myers Squibb
Immunomedics
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the US Celiac Disease Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the US Celiac Disease Market
Gluten-Free Grains
Gluten-Free Snacks
Gluten-Free Dairy Products
Gluten-Free Soups and Sauces
Gluten-Free Baked Goods
Supermarkets/Hypermarkets
Health Food Stores
Online Retail
Specialty Stores
Direct Sales
Adults
Children
Senior Citizens
Infants and Toddlers
Pregnant Women
Classical Celiac Disease
Non-Classical Celiac Disease
Silent Celiac Disease
Refractory Celiac Disease
Potential Celiac Disease
Organic Products
Non-Organic Products
Frozen/Chilled Products
Ready-to-Eat Products
Packaged Products
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Celiac Disease Market Research Analysis
1. Introduction of the US Celiac Disease Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. US Celiac Disease Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. US Celiac Disease Market, By Type
6. US Celiac Disease Market, By Application
7. US Celiac Disease Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. US Celiac Disease Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading US Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/